A letter was sent to a number of hospitals and systems, including Washington University in St. Louis, Southampton Healthcare in St. Louis and Children’s Mercy in Kansas City, according to an Aug. 30 news release.
The letter informed providers they “must immediately cease and desist performing gender transition surgeries on minors” and can no longer administer puberty blockers or cross-sex hormones to new patients, although they are allowed to continue providing those treatments to patients already receiving them before Aug. 28.
Under the SAFE Act, providers who knowingly violate the law can have their license revoked.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
